Profile

Cover photo
Arundhati Parmar
Works at UBM Canon
Attended Northwestern University
Lives in Minneapolis, MN 55416, United States
47 followers|5,755 views
AboutPostsPhotos

Stream

 
St. Jude Medical's CEO, Daniel Starks, is happy to grow organically and do small, tuck-in acquisitions where they make sense. He is not looking to merge with another company to grow bigger.  
Megamergers was the big trend in the medtech world in 2014, and analysts and experts alike believe that the move to a value-based healthcare system will require scale in the future. Bigger is better. So it would seem to make sense for smaller players like St. Jude Medical to merge with another company or be swallowed up by a bigger entity. Apparently not.
1
Add a comment...
 
mHealth devices have been largely divided into consumer tracking devices and apps on the one hand and clinical devices and apps prescribed by doctors. Now one San Diego #mhealth startup wants to provide clinical grade tracking and diagnostic ability to consumers.
The consumerization of healthcare together with the ever increasing need to know more about our bodies has given rise to the likes of FitBit, Samsung Gear, Apple's HealthKit, AliveCor's iPhone ECG device and innumerable other apps and devices. They tell us how we eat, sleep, exercise and track heart rate and other metrics too. They also tell our doctors whether we are gaining weight, whether we are experiencing abnormal heart rhythm and other clu...
1
Add a comment...
 
It's a bold move by Medtronic to buy Covidien but for its competitors its mainly bad news.
  In 2007 then Medtronic CEO Bill Hawkins spent $4 billion to buy spine company Kyphon, and when the deal didn't pan out, he was reportedly forced out. Current CEO Omar Ishrak will be spending 10 times that amount to buy Ireland-based Covidien. There's no doubt that in the future Ishrak's legacy will be determined by how well these two prominent medical technology companies integrate.
1
Add a comment...
 
How Medtronic is trying to own the heart failure condition from end to end.
  Last week MobiHealthNews reported that Medtronic has bought a wearable, noninvasive mobile cardiac telemetry company for $150 million. Medtronic will not comment on the rumored acquisition of Corventis, and it appears that the final price may be lower than $150 million. A Corventis representative did not respond to an email query. The low price-tag would seem to imply that it is a minor acquisition, and from a Wall Street perspective it probab...
1
Add a comment...
 
There is much talk these days about the medtech IPO market. Instead of sitting and watching their biotech brethren drink sweet ambrosia from public markets like they did last year, this year medtechs can partake of the fanfare too. But are medtech IPOs failing?
Last year, when biotech companies were flocking to the public markets, medtech companies were relegated to the sidelines watching the show. This year, however, medtech companies seem to be on an IPO tear.
1
Add a comment...
 
There have been many reports of how non-healthcare companies such as Apple and Google and Samsung are innovating in the healthcare space. And how they are encroaching on the device space with new and exciting digital devices. Wearables is one such category. This week Covidien emerged as a medtech trendsetter by acquiring Zephyr Technology. 
Covidien has quietly bought a wearables company - Annapolis, Maryland-based Zephyr Technology - as first reported by MobiHealthNews. It appears to be a small acquisition - the Dublin, Ireland-based company is not releasing transaction details but in an quarterly earnings filing revealed that it has acquired three companies in the first six months of fiscal 2014 for a grand total of $128 million.
1
Add a comment...
Have her in circles
47 people
Hugo Campos's profile photo
Jesus Fest's profile photo
Omkar Banerjee's profile photo
Norbert Sparrow's profile photo
Stephen Balek's profile photo
Camilla Andersson's profile photo
jo dinesh's profile photo
Austin Walters's profile photo
Mitesh Pandey's profile photo
 
Of swimsuits, beauty pageants and chronic disease ... http://ow.ly/zp5aM #showmeyourpump #medicaldevices #epatient #diabetes
Chronic disease is typically not assiciated with slim-legged, flat-bellied beauty. And yet, that is exactly the conversation that Type 1 Diabetic and Miss Idaho contestant chose to have when she donned a black swimsuit and wore her tslim touchscreen insulin pump from Tandem Diabetes proudly on stage.  But Sierra Sandison, the newly crowned Miss Idaho, didn't stop there.
2
Add a comment...
 
Patent trolls in medtech have been making their presence felt since about last year. Now one of these appears to have close ties to Medtronic. 
Patent assertion entities or patent monetization firms—sometimes called patent trolls—have been wreaking enough havoc in the high-tech world that Congress considered legislation, albeit unsucessfully. Since last year, the medtech industry is getting a taste of them as well. One such entity has been targeting several orthopedics firms, including industry giant Stryker. And it appears to have ties to one of the most prominent medical device compani...
1
Add a comment...

Arundhati Parmar

Shared publicly  - 
 
A conversation with the new chief of a medtech industry association shows medtech executives are wrestling with multiple, bewildering challenges. 
  There is a term for the seismic changes occurring in medtech and the broader healthcare marketplace today: I call it the "Atlas Shrugged" moment. Atlas of course is the Greek mythological figure charged with carrying the planet on his shoulders. Imagine him shrugging: If he does, the old world together with all its comfortable assumptions come crashing down.
3
Add a comment...
 
FDA gives the green signal to CardioMEMS' implantable wireless sensor for heart failure patient monitoring. Now hospitals have to choose between noninvasive remote patient monitoring through weight gain such as the one offered by Medtronic's CardioCom and St. Jude Medical's invasive PA pressure sensing technology.
After rejecting it the first time, FDA has approved the world’s first implantable wireless heart monitoring device to manage chronic heart failure patients remotely. Though approved, FDA is requiring a post-approval study to see how the CardioMEMS HF System performs outside of clinical trials.
1
Add a comment...
 
Defibrillators have caused many a headache for Boston Scientific's legal department in the past. Now, there is new interest in some of the company's defibrillators from the Department of Health and Human Services about launch and performance of some of its CRT-Ds and ICDs.
As important as defibrillators may be to Boston Scientific’s top and bottom lines, some in the firm's legal department may instead read them as a dirty word because of the headaches the Natick, Massachusetts company has endured over them in the past. Having bought Guidant and its defective heart devices in 2006, Boston Scientific ended up having to pay a penalty of $297 million after a district court in St.
1
Add a comment...
 
What is Covidien’s CEO's Take on Broader Implication of Zimmer-Biomet Deal?
Orthopedics company Zimmer Holdings took Wall Street and the medtech world by surprise when it announced last week that it is buying rival orthopedics firm Biomet for $13.35 billion. Zimmer was responding to market realities of implant pricing pressure, wrote one analyst in response to the announcement. Another opined that the deal creates a “formidable player” in the muskuloskeletal space. But what does this mean for medtech companies in other m...
1
Add a comment...
People
Have her in circles
47 people
Hugo Campos's profile photo
Jesus Fest's profile photo
Omkar Banerjee's profile photo
Norbert Sparrow's profile photo
Stephen Balek's profile photo
Camilla Andersson's profile photo
jo dinesh's profile photo
Austin Walters's profile photo
Mitesh Pandey's profile photo
Work
Occupation
Journalist
Skills
interviewing, story writing, editing, social media, taking video
Employment
  • UBM Canon
    Senior Editor, 2013 - present
    I cover the business of medical technology as well as innovation in the medtech industry.
Places
Map of the places this user has livedMap of the places this user has livedMap of the places this user has lived
Currently
Minneapolis, MN 55416, United States
Contact Information
Work
Phone
310-740-9054
Email
Story
Tagline
A healthcare journalist looking to learn about innovation and business strategy
Introduction
I cover business and innovation in the healthcare and medtech industry. Whether it be a quick provocative blog post, or an in-depth story, I am equally comfortable. I try to use video tools and social media tools to enhance my coverage.

In my free time, I love to cook, bake, teach my mother-tongue to my kids and watching suspense movies. I live in Minneapolis with my husband, son and daughter.
Bragging rights
Survived MN weather for 6 years in a row, first place in investigative category at the Page One awards given by the Minnesota chapter of the Society of Professional Journalists.
Education
  • Northwestern University
    Journalism, 2000 - 2001
    Master of Science in Journalism
  • University of Sydney
    English Literarature, 1999 - 1999
    Master of Arts
  • Jadavpur University
    English Honors, 1995 - 1998
Basic Information
Gender
Female
Links